Zhang, D., Baldwin, P., Leal, A. S., Carapellucci, S., Sridhar, S., & Liby, K. T. (2019). A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice. Theranostics.

Zhang, Di, Paige Baldwin, Ana S. Leal, Sarah Carapellucci, Srinivas Sridhar, and Karen T. Liby. "A Nano-liposome Formulation of the PARP Inhibitor Talazoparib Enhances Treatment Efficacy and Modulates Immune Cell Populations in Mammary Tumors of BRCA-deficient Mice." Theranostics 2019.

Zhang, Di, et al. "A Nano-liposome Formulation of the PARP Inhibitor Talazoparib Enhances Treatment Efficacy and Modulates Immune Cell Populations in Mammary Tumors of BRCA-deficient Mice." Theranostics 2019.